Home › Funds › PERCEPTIVE ADVISORS LLC › ABT
PERCEPTIVE ADVISORS LLC position in ABT
ABBOTT LABORATORIES · Health Care
PERCEPTIVE ADVISORS LLC reported holding 345,225 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$34.1M, representing 0.66% of its reported portfolio and ranking #30 among its reported holdings. PERCEPTIVE ADVISORS LLC first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How PERCEPTIVE ADVISORS LLC's ABT position evolved
PERCEPTIVE ADVISORS LLC first disclosed a stake in ABT in Q3 2026 at 345,225 shares (US$34.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 345.23K | $34.12M | New |
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 57.16M sh · $5.65B · Q3 2026
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 44.98M sh · $4.45B · Q3 2026
- Capital International Investors 35.46M sh · $3.51B · Q3 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Franklin Resources 20.44M sh · $2.36B · Q3 2026
- Deutsche Bank AG 17.69M sh · $1.75B · Q3 2026
- MFS Investment Management 14.93M sh · $1.48B · Q3 2026
More on PERCEPTIVE ADVISORS LLC
FAQ
How long has PERCEPTIVE ADVISORS LLC held ABT?
PERCEPTIVE ADVISORS LLC has disclosed ABT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is PERCEPTIVE ADVISORS LLC's current position in ABT?
As of Q3 2026, PERCEPTIVE ADVISORS LLC holds 345.23K shares of ABT (ABBOTT LABORATORIES), valued at $34.12M, representing 0.66% of its reported portfolio and ranking #30.
Has PERCEPTIVE ADVISORS LLC been buying or selling ABT?
In the latest 13F filing (Q3 2026), PERCEPTIVE ADVISORS LLC newly opened its position in ABT.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.